Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
Achaogen Inc. (NASDAQ: AKAO) shares declined 8.90 percent to close at $12.89 a share Monday. The stock traded between $12.25 and $14.35 on volume of 242,960 shares traded. Analysts at Credit Suisse have recently initiated coverage on the company with an "outperform" rating and a price target of $22.00. Shares of Achaogen have fallen approximately 10.0 percent year-to-date.
Find out more about Achaogen including full access to the free equity report at:
Align Technology, Inc. (NASDAQ: ALGN) shares declined 3.42 percent to close at $52.94 a share Monday. The stock traded between $52.50 and $55.59 on volume of 1.50 million shares traded. Analysts at Barrington Research have recently upgraded the company’s rating to "outperform" from "market perform". Shares of Align Technology have fallen approximately 7.0 percent year-to-date.
Find out more about Align Technology including full access to the free equity report at:
Calix Inc. (NYSE: CALX) shares increased 1.44 percent to close at $8.43 a share Monday. The stock traded between $8.26 and $8.66 on volume of 347,661 shares traded. Analysts at Craig-Hallum have recently initiated coverage on the company with a "buy" rating and a price target of $15.00. Shares of Calix have fallen approximately 12.0 percent year-to-date.
Find out more about Calix including full access to the free equity report at:
U.S. Geothermal Inc. (NYSEMKT: HTM) shares increased 7.70 percent to close at $0.73 a share Monday. The stock traded between $0.69 and $0.76 on volume of 1.38 million shares traded. Analysts at Canaccord Genuity have recently upgraded the company’s rating to "hold" from "sell". Shares of U.S. Geothermal have gained approximately 90.0 percent year-to-date.
Find out more about U.S. Geothermal including full access to the free equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Research Driven Investing